Position in ABUS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$471,474
+$79,754 QoQ
Shares Held
98,224
+12.8% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 175 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. ABUS ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ABUS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $471,474 | 98,224 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $391,720 | 87,049 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $470,777 | 97,875 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $445,958 | 98,229 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $265,976 | 86,077 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,879,812 | 538,629 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,930,762 | 896,258 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $344,904 | 89,586 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $249,445 | 80,727 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $227,379 | 88,132 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $288,697 | 115,479 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $241,569 | 119,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $241,639 | 105,061 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $891,318 | 294,165 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $169,725 | 72,844 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $133,191 | 69,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $173,956 | 64,191 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $175,599 | 58,926 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $166,246 | 42,737 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $161,350 | 37,611 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $104,916 | 34,626 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $116,922 | 35,112 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $127 | 36 | Shares | Defined | 2021-02-19 | |
| 2020-06-30 | $60 | 33 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||